Ecopetrol
EC
Oracle
ORCL
Petroleo Brasileiro SA Petrobras
PBR
Adobe
ADBE
Salesforce
CRM
US Stock MarketDetailed Quotes
CRBU Caribou Biosciences
- 1.420
- +0.070+5.19%
Close Feb 18 16:00 ET
- 1.410
- -0.010-0.70%
Post 16:15 ET
128.58MMarket Cap-0.86P/E (TTM)
1.460High1.330Low1.65MVolume1.340Open1.350Pre Close2.33MTurnover2.02%Turnover RatioLossP/E (Static)90.55MShares8.33052wk High0.46P/B115.82MFloat Cap1.22052wk Low--Dividend TTM81.56MShs Float32.645Historical High--Div YieldTTM9.63%Amplitude1.220Historical Low1.411Avg Price1Lot Size
About Caribou Biosciences Company
Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin Jinek and James Berger on October 28, 2011 and is headquartered in Berkeley, CA.
Company Profile
SymbolCRBU
Company NameCaribou Biosciences
Listing DateJul 23, 2021
Issue Price16.00
Founded2011
CEODr. Rachel Haurwitz, PhD
MarketNASDAQ
Employees158
Fiscal Year Ends12-31
Address2929 7th Street,Suite 105
CityBerkeley
ProvinceCalifornia
CountryUnited States of America
Zip Code94710
Phone1-510-982-6030
Websitehttp://www.cariboubio.com
Company Executives
- Name
- Position
- Salary
- Dr. Rachel Haurwitz, PhD
- President, Chief Executive Officer and Director
- 3.12M
- Barbara G. McClung, J.D.
- Chief Legal Officer and Corporate Secretary
- 1.22M
- Tim Kelly
- Chief Technology Officer
- --
- Ruhi Ahmad Khan
- Chief Business Officer
- --
- Sriram Ryali, M.B.A.
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Steven B. Kanner, PhD
- Chief Scientific Officer
- 1.22M
- Ryan Fischesser
- Vice President, Finance and Controller
- --
- Andrew L. Guggenhime
- Chairman of the Board
- 202.74K
- Dr. Dara Richardson-Heron
- Independent Director
- 141.93K
- Dr. Natalie Sacks
- Independent Director
- 136.99K
- Ran Zheng
- Independent Director
- 157.20K
- David L. Johnson, C.P.A.
- Independent Director
- 143.85K
- Dr. Nancy C. Whiting, Pharm.D.
- Independent Director
- 140.62K
- Dr. Scott Braunstein, M.D.
- Independent Director
- 155.86K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
